[The enhanced neuroleptic therapy and malignant syndrome].
D014150:Antipsychotic Agents / Q000009:adverse effects*; D001480:Basal Ganglia Diseases / Q000139:chemically induced; D003244:Consciousness Disorders / Q000139:chemically induced; D004359:Drug Therapy, Combination; D005334:Fever / Q000139:chemically induced; D006801:Humans; D008297:Male; D008875:Middle Aged; D013577:Syndrome
D014150:Antipsychotic Agents